| Literature DB >> 26164675 |
Sheetal P Silal1, Francesca Little2, Karen I Barnes3, Lisa J White4,5.
Abstract
BACKGROUND: South Africa is one of many countries committed to malaria elimination with a target of 2018 and all malaria-endemic provinces, including Mpumalanga, are increasing efforts towards this ambitious goal. The reduction of imported infections is a vital element of an elimination strategy, particularly if a country is already experiencing high levels of imported infections. Border control of malaria is one tool that may be considered.Entities:
Mesh:
Year: 2015 PMID: 26164675 PMCID: PMC4499227 DOI: 10.1186/s12936-015-0776-2
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1A map of Mpumalanga Province in relation to Mozambique and Swaziland [source: Mpumalanga Malaria Elimination Programme (unpublished)].
Figure 2Hybrid Metapopulation DE-IBM Model flow. a Compartment transmission model for each patch i (1–6) with sub-patch j (1–3) at time step t with compartments S susceptible, I infectious and treated (tr), C infectious, symptomatic and untreated (u), A infectious, asymptomatic and untreated, M Infectious, sub-patent and untreated and P susceptible with prior asymptomatic infection. b) Metapopulation structure highlighting human movement between each local patch and foreign patch 6. Other parameters are described in Table 1 and Additional file 1.
Values, descriptions and sources of the parameters driving the base metapopulation model of transmission ()
| Parameter | Description | Value | Source |
|---|---|---|---|
|
| Population size for the six patches |
| [ |
|
| Mortality/birth rate |
| [ |
|
| Period between liver stage and onset of gametocytemia | 2 weeks | [ |
|
| Artemether Lumefantrine elimination half-life | 6 days | [ |
|
| Time to seek treatment | 1/2 weeks | Expert opinion |
|
| Probability of treatment failure | 0.01 | [ |
|
| Proportion of local infected population receiving treatment | 0.95 | [ |
|
| Proportion of foreign infected population that receive treatment in a local patch |
| Estimated from model fitting process |
|
| Duration of clinical infection before becoming asymptomatic | 0.7 weeks | [ |
|
| Duration of asymptomatic infection before becoming sub-patent | 5.5 weeks | [ |
|
| Duration of sub-patent infection | 24 weeks | [ |
|
| Duration of clinical immunity | 5 years | [ |
|
| Probability of clinical infection from naive individuals | 0. 9997 (0.9756, 0.9999) | [ |
|
| Probability of clinical infection from partially immune individuals | 0.883 (0.877, 0.888) | Estimated from data |
|
| Seasonal forcing function for foreign sourced cases | Derived from data | [ |
|
| Annual number of mosquito bites per person × proportion of bites testing positive for sporozoites for patch |
| Estimated from model fitting process |
|
| Force of infection | See Additional file | |
|
| Rate of assimilation of population in sub-patch 2 (locals having returned from foreign travel) back into sub-patch 1 from whence they originated | 1.5 week−1 | Expert opinion |
|
| Rate of movement between five Mpumalanga municipalities | 1/ 201.436 (1/204.833, 1/198.040) week−1 | Estimated from model fitting process |
|
| Maputo residents: rate of movement between Maputo and five Mpumalanga municipalities |
| Estimated from model fitting process |
|
| Maputo residents: rate of movement between Maputo and 5 Mpumalanga municipalities based on | See Additional file | |
|
| Mpumalanga residents: rate of movement between 5 Mpumalanga municipalities and Maputo |
| Estimated from model fitting process |
|
| Mpumalanga residents: rate of movement between 5 Mpumalanga municipalities and Maputo based on | See Additional file | |
|
| Foreign movement weight intensity | 10.615 (10.512, 10.719) | Estimated from model fitting process |
|
| Local movement weight intensity | 1.419 (1.343, 1.495) | Estimated from model fitting process |
|
| Effectiveness of vector control | 0.9785 (0.9783, 0.9787) | Estimated from model fitting process |
|
| Vector control coverage in patch | Derived from data |
Figure 3FSAT IBM algorithm.
Values, descriptions and sources of the parameters driving the FSAT Individual Based Model
| Parameter | Description | Value | Source |
|---|---|---|---|
|
| Focal Screen and Treat Switch | Binary | |
|
| FSAT coverage | 25; 50; 75; 100% | Values to be tested |
| Baseline FSAT coverage | 70% | Assumed | |
|
| Proportion Screened and Treated through Border Control | fson | |
|
| Take-up proportion for FSAT | 25; 50; 75; 100% | Values to be tested |
|
| Probability of adherance | 0.90 | [ |
|
| Probability of treatment failure | 0.01 | [ |
|
| Number of screens tests performed simultaneously | 3 | Assumed |
|
| Geometric mean of log-normal parasite distribution for clinical infections | 25,000 | [ |
|
| Log standard deviation of log-normal parasite distribution for clinical infections | 1.3 | [ |
|
| Geometric mean of log-normal parasite distribution for asymptomatic infections | 1,000 | [ |
|
| Log standard deviation of log-normal parasite distribution for asymptomatic infections | 1.5 | [ |
|
| Geometric mean of log-normal parasite distribution for sub-patent infections | 50 | [ |
|
| Log standard deviation of log-normal parasite distribution for sub-patent infections | 0.75 | Assumed |
Descriptions of diagnostic tools used in FSAT model
| Tool | Detection threshold (parasites/µL) | Process time (h) | Target per week (tests per/h | Source |
|---|---|---|---|---|
| RDT | 200 | 0.33 | 504 | [ |
| Microscopy | 100 | 2.25 | 75 | Expert opinion, [ |
| qPCR | 1 | 3 | 63 | [ |
| LAMP | 5 | 1 | 168 | [ |
| Hypothetical RDT | 5 | 0.33 | 504 |
Figure 4Predicted weekly treated cases (blue 2002–2008; red 2009–2012) fitted to and validated with data (black). The 95% uncertainty range for weekly case predictions is shown.
Figure 5Predicted impact due to FSAT between 2014 and 2018 using the following diagnostic tools: microscopy (red), qPCR (orange), RDT (green), LAMP (blue) and a hypothetical RDT (purple). a Shows the percentage decrease in local infections due to the FSAT and b shows the impact of FSAT on local infections in Ehlanzeni district through time compared to the base case of no interventions (black).
Figure 6Predicted impact due to FSAT between 2014 and 2018. a Shows the percentage decrease in local infections due to the FSAT and b shows the impact of FSAT on local infections in Ehlanzeni district through time compared to the base case of no interventions (black). The impact of FSAT is predicted for different (1) coverage proportions, (2) thresholds of detections for the diagnostic tool used (parasites/µL), (3) take-up proportions, (4) coverage proportions for mass drug administration and (5) weekly targets (capacity) keeping all other variables constant. 95% confidence intervals are depicted for the average percentage decrease. The colours of the bars in (a) correspond to the level of local infections depicted in (b).
Sensitivity analysis of factors assessed in FSAT model
| Factor | Standardised regression coefficient | 95% confidence interval |
|---|---|---|
| Coverage | 0.41795 | (0.38181, 0.45409) |
| Take-up proportion | 0.36715 | (0.33100, 0.40329) |
| Adherence | 0.00095 | (−0.03520, 0.03709) |
| Detection threshold | −0.47861 | (−0.51475, −0.44247) |
| Target level | 0.34027 | (0.30413, 0.37642) |